THE SIGNIFICANCE OF INTERLEUKIN 2 IN THE DEVELOPMENT OF MULTIPLE MYELOMA
Keywords:
Multiple Myeloma, Interleukin 2 (IL-2), CytokinesAbstract
Multiple myeloma (MM) is a malignancy characterized by the proliferation of plasma cells in the bone marrow. The pathogenesis of MM is complex and involves various cytokines, among which Interleukin 2 (IL-2) plays a critical role. This article aims to review the significance of IL-2 in the development and progression of MM. The focus will be on the molecular mechanisms by which IL-2 influences MM cell growth, survival, and interaction with the bone marrow microenvironment. Understanding the role of IL-2 in MM could provide insights into potential therapeutic strategies targeting this cytokine.
Downloads
References
Palumbo, A., & Anderson, K. (2011). Multiple Myeloma. New England Journal of Medicine, 364(11), 1046-1060.
Gordon, M. S., & Kantoff, P. W. (1991). Interleukin-2 and cancer therapy. Cancer Investigation, 9(5), 411-420.
Küppers, R., & Dalla-Favera, R. (2001). Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene, 20(40), 5580-5594.
Rossi, J. F., Lu, Z. Y., Jourdan, M., & Klein, B. (1991). Interleukin-6 as a therapeutic target. Clinical Cancer Research, 11(9), 314-324.
Trentin, L., Zambello, R., Sancetta, R., & Semenzato, G. (1999). Interleukin-2 receptor expression in hematologic malignancies. Leukemia & Lymphoma, 34(5-6), 401-411.
Caligiuri, M. A., & Trinchieri, G. (1995). Interleukin-2 and the biology of natural killer cells. Advances in Immunology, 60, 127-173.
Costello, R. T., Boehrer, A., Sanchez, C., Mercier, D., Baier, C., Le Treut, T., ... & Olive, D. (2004). Differential expression of natural killer cell activating receptors in blood versus bone marrow in patients with multiple myeloma. Haematologica, 89(5), 587-591.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Muxamadalieva Gulchexra

This work is licensed under a Creative Commons Attribution 4.0 International License.
The content published on the International Scientific and Current Research Conferences platform, including conference papers, abstracts, and presentations, is made available under an open-access model. Users are free to access, share, and distribute this content, provided that proper attribution is given to the original authors and the source.